Published in J Cell Mol Med on March 17, 2016
Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis. Trends Endocrinol Metab (2016) 0.76
Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans. PLoS One (2016) 0.75
Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock. Circ Res (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature (2004) 12.72
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science (2002) 8.63
Sepsis: a roadmap for future research. Lancet Infect Dis (2015) 6.72
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest (2001) 5.05
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest (1995) 3.14
Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell (2011) 3.03
New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest (1979) 2.93
Inflammation impairs reverse cholesterol transport in vivo. Circulation (2009) 2.86
The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity (2007) 2.83
Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med (1994) 2.49
Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest (2009) 2.41
In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A (1993) 2.39
The role of albumin in critical illness. Br J Anaesth (2000) 2.33
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A (2011) 2.18
High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol (1995) 2.17
Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif (2012) 2.00
Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis (2009) 1.94
Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med (2005) 1.91
A novel human apolipoprotein (apoM). J Biol Chem (1999) 1.91
Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res (2008) 1.58
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood (2010) 1.56
Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J Cell Biol (2002) 1.51
Sphingosine kinases: a novel family of lipid kinases. Prog Nucleic Acid Res Mol Biol (2002) 1.43
Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol (2011) 1.34
Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun (2004) 1.30
High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function. J Biol Chem (2008) 1.23
An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma. J Lipid Res (2007) 1.22
Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest (1998) 1.21
The role of platelets in sepsis. Thromb Haemost (2014) 1.18
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11
Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res (1999) 1.10
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes. Crit Care (2012) 1.10
Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med (2009) 1.07
Evolving views of the major histocompatibility complex. Blood (1997) 1.06
Infection and inflammation decrease apolipoprotein M expression. Atherosclerosis (2007) 1.05
The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma. J Biol Chem (2008) 1.02
Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis. J Hepatol (2009) 1.00
Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate. FEBS Lett (1997) 1.00
Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Atherosclerosis (2013) 0.98
Characterization of apoM in normal and genetically modified mice. J Lipid Res (2004) 0.95
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal (2015) 0.94
Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M. J Lipid Res (2007) 0.93
Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. Biochim Biophys Acta (2004) 0.92
Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. J Biol Chem (2013) 0.91
HDL in infectious diseases and sepsis. Handb Exp Pharmacol (2015) 0.90
Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Crit Care (2015) 0.86
Pathophysiology, staging and therapy of severe sepsis in baboon models. J Cell Mol Med (2012) 0.84
Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels. Eur J Intern Med (2011) 0.84
Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. Acta Anaesthesiol Scand (2013) 0.83
Transforming growth factor-beta1 and major trauma: time-dependent association with hepatic and renal insufficiency. Shock (2003) 0.83
LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. J Biol Chem (2014) 0.81
Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation. Anal Bioanal Chem (2015) 0.81
Decreased plasma levels of the endothelial protective sphingosine-1-phosphate are associated with dengue-induced plasma leakage. J Infect (2015) 0.78
Elevated serum ApoE levels are associated with bacterial infections in pediatric patients. J Microbiol Immunol Infect (2013) 0.78
Multiple mouse models of primary lymphedema exhibit distinct defects in lymphovenous valve development. Dev Biol (2015) 0.82
Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ (2016) 0.75
Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine (2017) 0.75
HDL from end-stage renal disease patients exhibits superior cardioprotection and increase in S1P. Eur J Clin Invest (2017) 0.75